Aging and fountain-of-youth hormones

New England Journal of Medicine

Volumn 355, Issue 16, 2006, Pages 1724-1726

  Stewart, Paul M ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; HORMONE; PLACEBO; PRASTERONE; SEX HORMONE; TESTOSTERONE;

AGING; BONE DENSITY; EDITORIAL; HORMONE SUBSTITUTION; HUMAN; POSTMENOPAUSE; PRIORITY JOURNAL;

ADULT; AGED; AGING; BODY COMPOSITION; DEHYDROEPIANDROSTERONE; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; PHYSICAL FITNESS; TESTOSTERONE; TREATMENT FAILURE;

EID: 33750086353     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe068189     Document Type: Editorial

References (12)

1. Kaufman JM, Vermulen A. The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev 2005;26:833-76.
2. Baulieu EE. Androgens and aging men. Mol Cell Endocrinol 2002;198:41-9.
3. Arlt W. Dehydroepiandrosterone and ageing. Best Pract Res Clin Endocrinol Metab 2004;18:363-80.
4. Nair KS, Rizza RA, O'Brien P, et al. DHEA in elderly women and DHEA or testosterone in elderly men. N Engl J Med 2006;355:1647-59.
5. Baulieu EE, Thomas G, Legrain S, et al. Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue. Proc Natl Acad Sci U S A 2000;97:4279-84.
6. Percheron G, Hogrel JY, Denot-Ledunois S, et al. Effect of 1-year oral administration of dehydroepiandrosterone to 60- to 80-year-old individuals on muscle function and cross-sectional area: a double-blind placebo-controlled trial. Arch Intern Med 2003;163:720-7.
7. Muller M, van den Beld AW, van der Schouw YT, Grobbee DE, Lamberts SW. Effects of dehydroepiandrosterone and atamestane supplementation on frailty in elderly men. J Clin Endocrinol Metab (in press).
8. Villareal DT, Holloszy JO. Effect of DHEA on abdominal fat and insulin action in elderly women and men: a randomized controlled trial. JAMA 2004;292:2243-8.
9. Jankowski CM, Gozansky WS, Schwartz RS, et al. Effects of dehydroepiandrosterone replacement therapy on bone mineral density in older adults: a randomized, controlled trial. J Clin Endocrinol Metab 2006;91:2986-93.
10. Letter from the Food and Drug Administration to Peter Karpinski, April 9, 2001. (Accessed September 28, 2006, at http://www.fda.gov/cder/warn/cyber/2001/ Cyber105.pdf.)
11. Parasrampuria J, Schwartz K, Petesch R. Quality control of dehydroepiandrosterone dietary supplement products. JAMA 1998;280:1565.
12. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33.